Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rxrb
|
ENSMUSG00000039656.10 | retinoid X receptor beta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_34033332_34033483 | Rxrb | 145 | 0.804824 | -0.22 | 1.1e-01 | Click! |
chr17_34032971_34033178 | Rxrb | 478 | 0.413837 | -0.18 | 1.9e-01 | Click! |
chr17_34032127_34032647 | Rxrb | 14 | 0.839838 | -0.10 | 4.6e-01 | Click! |
chr17_34031958_34032127 | Rxrb | 154 | 0.579410 | 0.08 | 5.6e-01 | Click! |
chr17_34036723_34036891 | Rxrb | 344 | 0.590152 | -0.08 | 5.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_12293863_12294038 | 5.92 |
Actn2 |
actinin alpha 2 |
11403 |
0.16 |
chr7_46048797_46048961 | 4.79 |
Nomo1 |
nodal modulator 1 |
1242 |
0.33 |
chr2_27205685_27206025 | 4.74 |
Sardh |
sarcosine dehydrogenase |
4082 |
0.16 |
chr1_72969201_72969398 | 4.56 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
15545 |
0.22 |
chr14_14351950_14353283 | 4.52 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr4_133701094_133701537 | 3.81 |
Mir7227 |
microRNA 7227 |
15793 |
0.12 |
chr17_6749128_6749339 | 3.77 |
Ezr |
ezrin |
6412 |
0.18 |
chr4_156341977_156342304 | 3.77 |
Vmn2r125 |
vomeronasal 2, receptor 125 |
2060 |
0.28 |
chr9_49980492_49980798 | 3.45 |
Gm47543 |
predicted gene, 47543 |
25767 |
0.24 |
chr11_72407561_72408036 | 3.44 |
Smtnl2 |
smoothelin-like 2 |
3913 |
0.15 |
chr5_74159995_74160168 | 3.43 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
15969 |
0.14 |
chr6_50358160_50358718 | 3.41 |
Osbpl3 |
oxysterol binding protein-like 3 |
6482 |
0.27 |
chr14_24199908_24200059 | 3.32 |
Dlg5 |
discs large MAGUK scaffold protein 5 |
22194 |
0.13 |
chr7_125764515_125764737 | 3.31 |
D430042O09Rik |
RIKEN cDNA D430042O09 gene |
21629 |
0.21 |
chr4_135313282_135313975 | 3.29 |
Gm12982 |
predicted gene 12982 |
5658 |
0.12 |
chr1_91015310_91015461 | 3.24 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
16606 |
0.16 |
chr9_98428823_98429179 | 3.24 |
Rbp1 |
retinol binding protein 1, cellular |
6040 |
0.22 |
chr17_7538090_7538689 | 3.21 |
Gm33086 |
predicted gene, 33086 |
37801 |
0.17 |
chr2_72269737_72269928 | 3.20 |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
15805 |
0.16 |
chr11_95089540_95089691 | 3.17 |
Itga3 |
integrin alpha 3 |
12814 |
0.12 |
chr4_89433459_89434002 | 3.11 |
Gm12608 |
predicted gene 12608 |
10914 |
0.19 |
chr4_124652894_124653101 | 3.07 |
Pou3f1 |
POU domain, class 3, transcription factor 1 |
3810 |
0.14 |
chr5_51517896_51518055 | 3.05 |
Gm43605 |
predicted gene 43605 |
3682 |
0.2 |
chr7_19362280_19362625 | 3.04 |
Ppp1r13l |
protein phosphatase 1, regulatory subunit 13 like |
1236 |
0.2 |
chr8_36676498_36676826 | 3.02 |
Dlc1 |
deleted in liver cancer 1 |
56392 |
0.15 |
chr6_120987544_120988087 | 3.01 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
5097 |
0.17 |
chr16_26047963_26048140 | 2.99 |
AU015336 |
expressed sequence AU015336 |
6783 |
0.26 |
chr10_14017823_14018282 | 2.90 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51028 |
0.13 |
chr18_35675287_35675469 | 2.88 |
Dnajc18 |
DnaJ heat shock protein family (Hsp40) member C18 |
11365 |
0.08 |
chr5_51899713_51899923 | 2.87 |
Gm42617 |
predicted gene 42617 |
6604 |
0.18 |
chr3_83446129_83446447 | 2.84 |
Gm38096 |
predicted gene, 38096 |
42886 |
0.19 |
chr6_37735736_37735887 | 2.84 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
48616 |
0.15 |
chr10_76664705_76665060 | 2.82 |
Gm35608 |
predicted gene, 35608 |
19550 |
0.14 |
chr15_54114037_54114563 | 2.77 |
Gm26933 |
predicted gene, 26933 |
78318 |
0.11 |
chr18_61752118_61752269 | 2.76 |
1500015A07Rik |
RIKEN cDNA 1500015A07 gene |
17836 |
0.12 |
chr5_23874598_23874787 | 2.76 |
AC117663.1 |
solute carrier family 40 (iron-regulated transporter), member 1 (Slc40a1), pseudogene |
1751 |
0.21 |
chr8_41015080_41015419 | 2.73 |
Mtus1 |
mitochondrial tumor suppressor 1 |
1071 |
0.43 |
chr18_80336191_80336342 | 2.73 |
Gm26676 |
predicted gene, 26676 |
12931 |
0.13 |
chr10_31273229_31273616 | 2.72 |
Gm5422 |
predicted pseudogene 5422 |
25267 |
0.14 |
chr14_101872728_101872879 | 2.69 |
Lmo7 |
LIM domain only 7 |
3333 |
0.34 |
chr4_156343099_156343378 | 2.66 |
Vmn2r125 |
vomeronasal 2, receptor 125 |
962 |
0.53 |
chr19_36682632_36682867 | 2.63 |
Hectd2os |
Hectd2, opposite strand |
6524 |
0.24 |
chr13_59624965_59625118 | 2.60 |
Naa35 |
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
597 |
0.64 |
chr9_50753092_50753287 | 2.59 |
Cryab |
crystallin, alpha B |
169 |
0.85 |
chr11_61028356_61028507 | 2.58 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
5867 |
0.2 |
chr4_57606473_57606624 | 2.58 |
Pakap |
paralemmin A kinase anchor protein |
31275 |
0.21 |
chr19_61225302_61226760 | 2.55 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr6_83598147_83598298 | 2.55 |
Gm7424 |
predicted gene 7424 |
3486 |
0.15 |
chr1_91350904_91351157 | 2.52 |
Klhl30 |
kelch-like 30 |
14 |
0.96 |
chr17_72976972_72977179 | 2.51 |
Gm23649 |
predicted gene, 23649 |
10723 |
0.22 |
chr4_150769131_150769447 | 2.51 |
Gm13049 |
predicted gene 13049 |
56444 |
0.1 |
chr6_120109328_120109515 | 2.49 |
Ninj2 |
ninjurin 2 |
16071 |
0.18 |
chr11_97699300_97700660 | 2.45 |
Pcgf2 |
polycomb group ring finger 2 |
332 |
0.72 |
chr3_127698278_127698609 | 2.44 |
Gm16238 |
predicted gene 16238 |
5923 |
0.12 |
chr17_65101326_65101489 | 2.43 |
Gm49865 |
predicted gene, 49865 |
67796 |
0.13 |
chr12_99671260_99671451 | 2.42 |
Gm19951 |
predicted gene, 19951 |
28262 |
0.13 |
chr12_102416431_102416794 | 2.41 |
Lgmn |
legumain |
7157 |
0.19 |
chr3_88603769_88604137 | 2.41 |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
2013 |
0.16 |
chr14_54984493_54984644 | 2.37 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
2850 |
0.09 |
chr10_80948620_80948940 | 2.37 |
Gm3828 |
predicted gene 3828 |
5930 |
0.1 |
chr2_33361430_33361623 | 2.37 |
Gm25998 |
predicted gene, 25998 |
1520 |
0.35 |
chr11_99055574_99055970 | 2.35 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
8461 |
0.12 |
chr6_72263853_72264014 | 2.34 |
Atoh8 |
atonal bHLH transcription factor 8 |
28356 |
0.12 |
chr3_53707246_53707397 | 2.33 |
Gm6204 |
predicted gene 6204 |
14443 |
0.13 |
chr9_41697271_41698297 | 2.31 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr18_54174740_54175026 | 2.30 |
Gm8594 |
predicted gene 8594 |
143575 |
0.05 |
chr1_91313342_91313536 | 2.30 |
Gm17090 |
predicted gene 17090 |
7662 |
0.11 |
chr8_36952122_36952343 | 2.29 |
Dlc1 |
deleted in liver cancer 1 |
125 |
0.97 |
chr16_90453004_90453155 | 2.28 |
Hunk |
hormonally upregulated Neu-associated kinase |
8818 |
0.21 |
chr1_89015543_89015716 | 2.26 |
1700067G17Rik |
RIKEN cDNA 1700067G17 gene |
484 |
0.81 |
chr2_174018003_174018375 | 2.26 |
Vamp7-ps |
vesicle-associated membrane protein 7, pseudogene |
29084 |
0.15 |
chr16_33594418_33594785 | 2.25 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
1961 |
0.44 |
chr17_56472537_56473329 | 2.25 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr6_124925968_124926175 | 2.24 |
Mlf2 |
myeloid leukemia factor 2 |
5315 |
0.08 |
chr2_150770474_150770661 | 2.24 |
Pygb |
brain glycogen phosphorylase |
16168 |
0.13 |
chr14_32956280_32956847 | 2.23 |
Lrrc18 |
leucine rich repeat containing 18 |
34819 |
0.15 |
chr15_36985695_36985846 | 2.23 |
Zfp706 |
zinc finger protein 706 |
16265 |
0.16 |
chr2_43404671_43404864 | 2.21 |
Gm13464 |
predicted gene 13464 |
114631 |
0.07 |
chr14_27229627_27229808 | 2.21 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
8322 |
0.18 |
chr9_31148162_31148679 | 2.20 |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
5225 |
0.19 |
chr11_52275479_52275630 | 2.19 |
A630014C17Rik |
RIKEN cDNA A630014C17 gene |
501 |
0.52 |
chr13_111296062_111296428 | 2.19 |
Actbl2 |
actin, beta-like 2 |
41232 |
0.13 |
chr5_118425140_118425536 | 2.18 |
Gm26455 |
predicted gene, 26455 |
6520 |
0.21 |
chr2_107125684_107125835 | 2.18 |
Gm13903 |
predicted gene 13903 |
1799 |
0.38 |
chr16_97897823_97897974 | 2.17 |
C2cd2 |
C2 calcium-dependent domain containing 2 |
5617 |
0.19 |
chr9_59706996_59707295 | 2.17 |
Gramd2 |
GRAM domain containing 2 |
492 |
0.74 |
chr11_78829414_78829738 | 2.17 |
Lyrm9 |
LYR motif containing 9 |
2947 |
0.22 |
chr1_74054042_74054388 | 2.14 |
Tns1 |
tensin 1 |
17058 |
0.19 |
chr4_130036265_130036627 | 2.14 |
Gm12963 |
predicted gene 12963 |
7942 |
0.14 |
chr5_134014531_134015255 | 2.13 |
1700030N18Rik |
RIKEN cDNA 1700030N18 gene |
76558 |
0.08 |
chr2_163392280_163392431 | 2.13 |
Jph2 |
junctophilin 2 |
5594 |
0.15 |
chr4_149954471_149955779 | 2.11 |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
82 |
0.97 |
chr8_44456225_44456377 | 2.10 |
Gm26241 |
predicted gene, 26241 |
91773 |
0.09 |
chr19_31751411_31751563 | 2.10 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
13486 |
0.28 |
chr16_77331084_77331348 | 2.10 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1712 |
0.33 |
chr7_143124014_143124583 | 2.09 |
Gm38321 |
predicted gene, 38321 |
271 |
0.85 |
chr14_101886174_101886385 | 2.09 |
Lmo7 |
LIM domain only 7 |
2160 |
0.42 |
chr19_4436420_4436571 | 2.09 |
A930001C03Rik |
RIKEN cDNA A930001C03 gene |
2508 |
0.17 |
chr10_89522168_89522319 | 2.06 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
11342 |
0.21 |
chr7_84018766_84019085 | 2.06 |
Cemip |
cell migration inducing protein, hyaluronan binding |
42850 |
0.13 |
chr8_95358736_95359112 | 2.06 |
Mmp15 |
matrix metallopeptidase 15 |
6656 |
0.13 |
chr5_144267961_144268298 | 2.05 |
Gm15708 |
predicted gene 15708 |
8932 |
0.12 |
chr12_54789799_54790067 | 2.04 |
Snx6 |
sorting nexin 6 |
5549 |
0.12 |
chr2_63273724_63274213 | 2.04 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
89681 |
0.09 |
chr14_8111668_8111863 | 2.03 |
Pxk |
PX domain containing serine/threonine kinase |
13510 |
0.18 |
chr16_37728764_37728915 | 2.03 |
Gm4600 |
predicted gene 4600 |
31499 |
0.15 |
chr6_50978737_50978888 | 2.01 |
Gm44402 |
predicted gene, 44402 |
11544 |
0.23 |
chr11_120386595_120387016 | 2.00 |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
3302 |
0.11 |
chrX_12105563_12105783 | 2.00 |
Bcor |
BCL6 interacting corepressor |
22677 |
0.23 |
chr18_64683616_64683798 | 1.99 |
Gm50352 |
predicted gene, 50352 |
1403 |
0.32 |
chr1_12734561_12734712 | 1.98 |
Sulf1 |
sulfatase 1 |
6517 |
0.24 |
chr1_73969044_73969527 | 1.97 |
Tns1 |
tensin 1 |
6242 |
0.25 |
chr5_122927155_122927306 | 1.97 |
Kdm2b |
lysine (K)-specific demethylase 2B |
5123 |
0.15 |
chr5_53472612_53472763 | 1.97 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
6535 |
0.21 |
chr1_74018273_74018424 | 1.97 |
Tns1 |
tensin 1 |
1926 |
0.39 |
chr13_97883742_97883893 | 1.97 |
Gm34388 |
predicted gene, 34388 |
7155 |
0.22 |
chr17_31834757_31834978 | 1.96 |
Sik1 |
salt inducible kinase 1 |
16708 |
0.15 |
chrX_59220881_59221032 | 1.96 |
Gm14890 |
predicted gene 14890 |
23993 |
0.19 |
chr2_72391094_72391351 | 1.96 |
Rpl36a-ps4 |
ribosomal protein L36A, pseudogene 4 |
30975 |
0.18 |
chr10_76642712_76643426 | 1.96 |
Col6a2 |
collagen, type VI, alpha 2 |
19439 |
0.14 |
chr5_23672167_23672512 | 1.95 |
Gm24009 |
predicted gene, 24009 |
2042 |
0.21 |
chr1_129101142_129101329 | 1.95 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
172067 |
0.03 |
chr8_45469566_45469946 | 1.95 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
38032 |
0.13 |
chr13_112764832_112765092 | 1.95 |
Gm47850 |
predicted gene, 47850 |
114 |
0.96 |
chr8_54393544_54393765 | 1.94 |
Gm45553 |
predicted gene 45553 |
120496 |
0.06 |
chr19_56761302_56761453 | 1.93 |
Gm6990 |
predicted pseudogene 6990 |
6031 |
0.16 |
chr19_36168336_36168487 | 1.93 |
Gm32081 |
predicted gene, 32081 |
14169 |
0.19 |
chr11_68554196_68554347 | 1.92 |
Mfsd6l |
major facilitator superfamily domain containing 6-like |
1915 |
0.26 |
chr8_61665080_61665513 | 1.92 |
Palld |
palladin, cytoskeletal associated protein |
74154 |
0.11 |
chrX_7287132_7287401 | 1.92 |
Clcn5 |
chloride channel, voltage-sensitive 5 |
31904 |
0.09 |
chr18_37879692_37880425 | 1.92 |
Diaph1 |
diaphanous related formin 1 |
17884 |
0.08 |
chr1_156462647_156462961 | 1.92 |
Soat1 |
sterol O-acyltransferase 1 |
4000 |
0.19 |
chr2_119236988_119237799 | 1.91 |
Spint1 |
serine protease inhibitor, Kunitz type 1 |
31 |
0.95 |
chr13_103015222_103015373 | 1.89 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
56830 |
0.16 |
chr2_120102996_120103168 | 1.89 |
Sptbn5 |
spectrin beta, non-erythrocytic 5 |
17404 |
0.13 |
chr8_12883054_12883339 | 1.89 |
Gm15353 |
predicted gene 15353 |
520 |
0.67 |
chr2_43404235_43404399 | 1.87 |
Gm13464 |
predicted gene 13464 |
115081 |
0.07 |
chr14_46885106_46885668 | 1.87 |
2810457G06Rik |
RIKEN cDNA 2810457G06 gene |
323 |
0.74 |
chr15_101240803_101241216 | 1.87 |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
13260 |
0.09 |
chr8_47363329_47363588 | 1.86 |
Stox2 |
storkhead box 2 |
11110 |
0.24 |
chr6_111584928_111585237 | 1.86 |
Gm22093 |
predicted gene, 22093 |
18170 |
0.28 |
chr11_4303233_4303384 | 1.85 |
Gm11958 |
predicted gene 11958 |
17848 |
0.11 |
chr10_63476864_63477015 | 1.84 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
19429 |
0.18 |
chr6_127989413_127989573 | 1.84 |
Tspan9 |
tetraspanin 9 |
22676 |
0.16 |
chr16_5186307_5186458 | 1.84 |
Nagpa |
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
11383 |
0.1 |
chr16_34494091_34494303 | 1.83 |
Kalrn |
kalirin, RhoGEF kinase |
19747 |
0.27 |
chr14_70056303_70056528 | 1.82 |
Gm33524 |
predicted gene, 33524 |
952 |
0.53 |
chr5_14949744_14950125 | 1.81 |
Speer4e |
spermatogenesis associated glutamate (E)-rich protein 4e |
11505 |
0.19 |
chr1_74007725_74008174 | 1.81 |
Tns1 |
tensin 1 |
6382 |
0.25 |
chr19_53008463_53008657 | 1.80 |
Mir6407 |
microRNA 6407 |
2196 |
0.27 |
chr11_120703837_120703988 | 1.80 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
1398 |
0.17 |
chr10_36754581_36754732 | 1.79 |
Gm22554 |
predicted gene, 22554 |
21275 |
0.27 |
chr2_85107297_85107474 | 1.79 |
4930443O20Rik |
RIKEN cDNA 4930443O20 gene |
20924 |
0.11 |
chr13_29377695_29377864 | 1.78 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
96828 |
0.08 |
chr1_155233440_155234889 | 1.77 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr5_31627217_31627368 | 1.77 |
Mrpl33 |
mitochondrial ribosomal protein L33 |
13140 |
0.1 |
chr17_78791500_78791895 | 1.77 |
Heatr5b |
HEAT repeat containing 5B |
4416 |
0.16 |
chr8_122656165_122656442 | 1.77 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
9837 |
0.1 |
chr11_98392004_98392368 | 1.76 |
Pgap3 |
post-GPI attachment to proteins 3 |
114 |
0.91 |
chr6_135049088_135049306 | 1.76 |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
16454 |
0.14 |
chr5_134788226_134788544 | 1.76 |
Eln |
elastin |
41062 |
0.1 |
chr11_72094289_72094440 | 1.76 |
Pitpnm3 |
PITPNM family member 3 |
32803 |
0.12 |
chr4_136143104_136143903 | 1.74 |
Id3 |
inhibitor of DNA binding 3 |
6 |
0.97 |
chr17_35701467_35701700 | 1.73 |
Ddr1 |
discoidin domain receptor family, member 1 |
381 |
0.67 |
chr19_24049400_24049660 | 1.72 |
1700021P04Rik |
RIKEN cDNA 1700021P04 gene |
15263 |
0.16 |
chr2_158065173_158065338 | 1.72 |
Rprd1b |
regulation of nuclear pre-mRNA domain containing 1B |
17296 |
0.15 |
chr8_47218677_47218836 | 1.72 |
Stox2 |
storkhead box 2 |
1437 |
0.44 |
chr15_99036533_99036802 | 1.71 |
Tuba1c |
tubulin, alpha 1C |
6346 |
0.09 |
chr14_23590073_23590224 | 1.71 |
Gm29626 |
predicted gene 29626 |
29883 |
0.19 |
chr2_167249691_167249873 | 1.70 |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
9178 |
0.15 |
chr12_86652768_86653097 | 1.70 |
Gm22004 |
predicted gene, 22004 |
2193 |
0.23 |
chr12_103969871_103970197 | 1.70 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
11059 |
0.1 |
chr7_118309814_118309992 | 1.70 |
Gm35309 |
predicted gene, 35309 |
19583 |
0.13 |
chr2_76807304_76807608 | 1.70 |
Ttn |
titin |
19086 |
0.23 |
chr18_11392849_11393083 | 1.70 |
Gm50067 |
predicted gene, 50067 |
231949 |
0.02 |
chr15_37724398_37724549 | 1.69 |
Gm49397 |
predicted gene, 49397 |
9862 |
0.16 |
chr4_129508213_129508374 | 1.69 |
Gm12979 |
predicted gene 12979 |
1453 |
0.21 |
chr14_76804575_76804726 | 1.68 |
Gm30246 |
predicted gene, 30246 |
23823 |
0.16 |
chr7_81684186_81684349 | 1.67 |
Homer2 |
homer scaffolding protein 2 |
8620 |
0.14 |
chr15_5927877_5928058 | 1.67 |
Gm49095 |
predicted gene, 49095 |
23477 |
0.2 |
chr3_28431586_28431737 | 1.67 |
Mir466q |
microRNA 466q |
11718 |
0.22 |
chr5_105829341_105829492 | 1.67 |
Lrrc8d |
leucine rich repeat containing 8D |
4905 |
0.15 |
chr9_67565772_67565948 | 1.67 |
Tln2 |
talin 2 |
6157 |
0.28 |
chr11_4196645_4196957 | 1.66 |
Tbc1d10a |
TBC1 domain family, member 10a |
8622 |
0.1 |
chr6_90731372_90731569 | 1.66 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
5217 |
0.19 |
chr17_13487667_13487820 | 1.65 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
12593 |
0.12 |
chr9_103679383_103679534 | 1.64 |
Tmem108 |
transmembrane protein 108 |
13349 |
0.22 |
chr13_56828420_56828571 | 1.64 |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
59621 |
0.12 |
chr11_76196773_76196972 | 1.64 |
Fam57a |
family with sequence similarity 57, member A |
5143 |
0.14 |
chr9_14608646_14608826 | 1.63 |
Amotl1 |
angiomotin-like 1 |
5850 |
0.13 |
chr4_133117517_133117896 | 1.63 |
Wasf2 |
WAS protein family, member 2 |
12799 |
0.17 |
chr13_46883597_46883763 | 1.62 |
Gm48250 |
predicted gene, 48250 |
2653 |
0.22 |
chr13_12317316_12317467 | 1.62 |
Actn2 |
actinin alpha 2 |
23333 |
0.15 |
chr8_23379771_23380141 | 1.62 |
Sfrp1 |
secreted frizzled-related protein 1 |
31546 |
0.18 |
chr4_148833748_148833899 | 1.61 |
Casz1 |
castor zinc finger 1 |
29358 |
0.17 |
chr16_21370010_21370180 | 1.61 |
Magef1 |
melanoma antigen family F, 1 |
36739 |
0.15 |
chr18_68119000_68119356 | 1.61 |
Gm41764 |
predicted gene, 41764 |
804 |
0.7 |
chr19_47438433_47438849 | 1.60 |
Sh3pxd2a |
SH3 and PX domains 2A |
25606 |
0.17 |
chr11_83448079_83448269 | 1.60 |
1700020L24Rik |
RIKEN cDNA 1700020L24 gene |
8043 |
0.11 |
chr13_3726355_3726552 | 1.60 |
Gm47695 |
predicted gene, 47695 |
33372 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 1.6 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.5 | 1.5 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.9 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 0.8 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 1.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 1.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 1.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 1.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 1.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 1.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 1.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 1.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 0.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.3 | 0.8 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.3 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 1.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 0.5 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.5 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.3 | 0.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.8 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.3 | 0.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 2.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.7 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 1.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 2.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.2 | 0.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.2 | 0.2 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.2 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.6 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 0.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.8 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.2 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 1.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.8 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 1.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.7 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 1.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 1.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 1.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.2 | 1.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.5 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.6 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 1.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 6.7 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 0.5 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 1.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 1.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.1 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 2.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.1 | 0.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.7 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 1.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.2 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.4 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 1.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.5 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.7 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.5 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 1.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.3 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 1.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 1.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 1.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.1 | 0.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.5 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.8 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.9 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.2 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:1902337 | regulation of apoptotic process involved in morphogenesis(GO:1902337) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.1 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.2 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.1 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 1.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 1.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.0 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 1.5 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.0 | 0.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.0 | 0.0 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0045472 | response to ether(GO:0045472) |
0.0 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.1 | GO:0090381 | heart induction(GO:0003129) regulation of heart induction(GO:0090381) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.2 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.5 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 1.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.0 | 0.2 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.4 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.5 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.0 | GO:0001807 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.5 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.0 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) |
0.0 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.0 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.0 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.3 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.6 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.0 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.1 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0060740 | prostate gland epithelium morphogenesis(GO:0060740) |
0.0 | 0.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.5 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.0 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.2 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.0 | 0.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.3 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0060558 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) regulation of calcidiol 1-monooxygenase activity(GO:0060558) cellular response to nicotine(GO:0071316) response to glycoside(GO:1903416) |
0.0 | 0.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.0 | 0.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.0 | 0.1 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.0 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.2 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.3 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 1.7 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.0 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 1.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 2.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 3.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 7.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.5 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 2.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 2.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 3.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.8 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 3.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.2 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 2.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 2.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 6.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 1.6 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 2.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 3.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 1.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 2.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 3.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.0 | GO:0018638 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 3.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 2.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 1.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 1.0 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.9 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 3.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.7 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 1.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 1.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 1.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.0 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 1.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 3.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 10.1 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 1.0 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.2 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.4 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 1.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 1.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.0 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 1.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.2 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 6.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 5.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 3.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.0 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 3.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 5.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 1.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 2.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |